What is the difference between MGF and Sermorelin?

MGF: MGF (Mechano Growth Factor) is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical loading (exercise, especially eccentric loading). Unlike circulating IGF-1 which is produced primarily by the liver, MGF is generated within the muscle itself and acts locally to activate satellite cells (muscle stem cells) — the cells responsible for muscle repair, growth, and adaptation. It is considered the primary local anabolic signal generated by resistance training. Sermorelin: Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take MGF and Sermorelin together?

There is no specific, well-documented interaction rule for combining MGF and Sermorelin in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, MGF or Sermorelin?

MGF is currently preclinical only and Sermorelin is fda-approved. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

MGF vs Sermorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

MGF

Preclinical only

MGF (Mechano Growth Factor) is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical loading (exercise, especially eccentric loading). Unlike circulating IGF-1 which is produced primarily by the liver, MGF is generated within the muscle itself and acts locally to activate satellite cells (muscle stem cells) — the cells responsible for muscle repair, growth, and adaptation. It is considered the primary local anabolic signal generated by resistance training.

Full profile

Sermorelin

FDA-approved

Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.

Full profile

	MGF	Sermorelin
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	Mechano Growth Factor, IGF-1Ec, Insulin-like Growth Factor splice variant	GHRH 1-29, GRF 1-29 NH2, Geref
Evidence	Preclinical only	FDA-approved
Dosing range	100mcg–300mcg mcg, Post-workout (within 30–60 minutes of training), 3–4x weekly	100mcg–500mcg mcg, once daily (before sleep)
Administration	Intramuscular injection (into worked muscle — critical for local effect), Subcutaneous injection (produces more systemic distribution)	Subcutaneous injection
Key side effects	Localized muscle swelling at injection site (normal response), Hypoglycemia (less pronounced than IGF-1 DES but present), Very short half-life means side effects are brief, Potential overuse injury if post-workout injection is used consistently without adequate recovery	Injection site redness, Headache, Flushing, Dizziness
Cited sources	3 references	1 reference

Key differences

Evidence level differs: MGF is preclinical only, while Sermorelin is fda-approved.
Administration: MGF — Intramuscular injection (into worked muscle — critical for local effect), Subcutaneous injection (produces more systemic distribution); Sermorelin — Subcutaneous injection.
Frequency: MGF is typically Post-workout (within 30–60 minutes of training), 3–4x weekly; Sermorelin is once daily (before sleep).
Research depth: this profile cites 3 sources for MGF vs 1 for Sermorelin.

How each works

MGF

MGF is encoded by the IGF-1 gene but produced via alternative splicing that generates a unique 49-amino acid C-terminal E-peptide (Ec peptide). The Ec peptide has distinct biological activity from the IGF-1 domain — it directly activates satellite cell proliferation through a receptor pathway separate from the standard IGF-1R. Studies in rodents show that local MGF injection produces significant muscle hypertrophy in the injected limb without systemic IGF-1 elevation. MGF expression spikes within 30 minutes of resistance exercise and declines over 24–48 hours — aligning precisely with the post-exercise anabolic window.

Sermorelin

Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.

Read the full MGF profile Read the full Sermorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.